Skip to main content

Table 1 Growth data of the subjects compared to the controls

From: Weight loss on stimulant medication: how does it affect body composition and bone metabolism? – A prospective longitudinal study

 

All subjects

All subjects

All subjects

DXA Controls

Baseline n=34

6 months n=30

36 months n=24

n=241

Mean ± sd

Range

Mean ± sd

Range

Mean ± sd

Range

Mean ± sd

Range

Age (years)

7.27 ± 1.30***

4.71-9.12

7.99 ± 1.21*

5.33-9.64

10.49 ± 1.22***

7.87-12.21

8.54 ± 1.93

4.02-11.99

Height (cm)

125.5 ± 9.1*

110.3-142.2

128.6 ± 9.2

112.6-145.6

140.6 ± 9.0***

125.5-156.0

130.5 ± 12.7

94.5-161.6

Weight (kg)

27.0 ± 6.1

19.1-42.1

26.8 ± 5.9

19.3-42.2

34.4 ± 8.4**

25.0-56.0

29.0 ± 8.2

13.1-60.4

BMI (kg/m2)

17.0 ± 2.3

13.7-23.7

16.1 ± 2.3

12.9-23.0

17.3 ± 3.1

13.9-26.5

16.7 ± 2.2

13.3-25.6

Height Z-score

0.49 ± 0.99**

−1.08-3.02

0.22 ± 0.95

−1.19-2.76

−0.07 ± 0.81

−1.18-1.67

−0.06 ± 0.97

−2.24-2.07

Weight Z-score

0.62 ± 0.97***

−1.60-2.95

0.04 ± 1.04

−1.86-2.63

−0.12 ± 0.87

−1.48-1.58

−0.05 ± 0.92

−2.25-2.23

BMI Z-score

0.52 ± 1.02**

−1.88-2.31

−0.17 ± 1.21

−2.92-2.04

−0.16 ± 1.11

−2.45-1.97

0.03 ± 0.88

−2.11-2.09

  1. *p<0.05; **p<0.01; ***p<0.001 compared to DXA controls (independent samples t-test).
  2. DXA: Dual-energy X-ray absorptiometry.